Gfp - my question in #msg-16569691 was referring to the situation that I would guess exists, i.e. everyone and their brother knows the details of which organ was involved, what the histo abnormality was, etc... *except* us - i.e. the small investors.
I don't think it's realistic to believe that Cortex's competitors don't already know all of the details involved in Cortex's CX-717 problems with the FDA, that's what I was curious in getting a response on.
Maybe that info can realistically be kept confidential, but it seems unlikely to me.
Which makes it all the more frustrating that small investors are the only ones that don't know info that might help in investing decisions, e.g. which organ is involved, what the dosing limitations are, etc... Aiming4.